Risks of gene therapy should be weighed against lack of alternatives for many diseases

BMJ. 2005 Apr 2;330(7494):791. doi: 10.1136/bmj.330.7494.791-a.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Genetic Therapy / adverse effects*
  • Humans
  • Leukemia, T-Cell / therapy
  • Risk Assessment
  • Risk Factors
  • Severe Combined Immunodeficiency / therapy